NO20041295L - Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitet - Google Patents
Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitetInfo
- Publication number
- NO20041295L NO20041295L NO20041295A NO20041295A NO20041295L NO 20041295 L NO20041295 L NO 20041295L NO 20041295 A NO20041295 A NO 20041295A NO 20041295 A NO20041295 A NO 20041295A NO 20041295 L NO20041295 L NO 20041295L
- Authority
- NO
- Norway
- Prior art keywords
- tieno
- oxazin
- ones
- inhibitory activity
- lipase inhibitory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0121019A GB0121019D0 (en) | 2001-08-30 | 2001-08-30 | /nhibitors |
GB0206031A GB0206031D0 (en) | 2002-03-14 | 2002-03-14 | Inhibitors |
PCT/GB2002/003903 WO2003020282A1 (en) | 2001-08-30 | 2002-08-23 | Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20041295L true NO20041295L (no) | 2004-03-29 |
Family
ID=26246489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20041295A NO20041295L (no) | 2001-08-30 | 2004-03-29 | Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitet |
Country Status (20)
Country | Link |
---|---|
US (2) | US7407954B2 (ko) |
EP (1) | EP1446125B1 (ko) |
JP (2) | JP2005527469A (ko) |
KR (1) | KR100934256B1 (ko) |
CN (1) | CN1556706B (ko) |
AR (1) | AR036399A1 (ko) |
AT (1) | ATE429918T1 (ko) |
AU (1) | AU2002321536B2 (ko) |
CA (1) | CA2458213A1 (ko) |
DE (1) | DE60232170D1 (ko) |
HK (1) | HK1064940A1 (ko) |
HU (1) | HUP0401298A3 (ko) |
MX (1) | MXPA04001922A (ko) |
MY (1) | MY139608A (ko) |
NO (1) | NO20041295L (ko) |
NZ (1) | NZ531272A (ko) |
PL (1) | PL368994A1 (ko) |
RU (1) | RU2324696C2 (ko) |
WO (1) | WO2003020282A1 (ko) |
ZA (1) | ZA200401595B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60232170D1 (de) * | 2001-08-30 | 2009-06-10 | Alizyme Therapeutics Ltd | Thieno-(1,3)-oxazin-4-one mit lipase inhibierender wirkung |
CN1620439A (zh) * | 2001-12-20 | 2005-05-25 | Osi药物公司 | 胰脂肪酶抑制剂化合物、其合成方法和应用 |
US20090143411A1 (en) * | 2004-10-20 | 2009-06-04 | Compass Pharmaceuticals Llc | Thiophens and Their Use as Anti-Tumor Agents |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
DE3540377A1 (de) * | 1985-11-14 | 1987-05-21 | Bayer Ag | Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer |
IL125947A0 (en) | 1997-09-17 | 1999-04-11 | American Cyanamid Co | 3-(1,2-benzisothiazol- and isoxazol-5-yl)-2,4(1h,3h)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3)-pyrimidinone or thione herbicidal agents |
EP0985670A1 (en) | 1998-08-13 | 2000-03-15 | American Cyanamid Company | 1-(3-Heterocyclylphenyl)isothiourea, -isourea, -guanidine and -amidine compounds as herbicides |
WO2000030646A1 (en) | 1998-11-26 | 2000-06-02 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
GB9900416D0 (en) * | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
AR022204A1 (es) | 1999-01-08 | 2002-09-04 | Norgine Bv | Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende. |
EP1212098A2 (en) | 1999-09-10 | 2002-06-12 | The Procter & Gamble Company | Enzyme inhibitors |
GB0001572D0 (en) | 2000-01-24 | 2000-03-15 | Alizyme Therapeutics Ltd | Inhibitors |
JP2002105081A (ja) | 2000-07-28 | 2002-04-10 | Nikken Chem Co Ltd | 新規チオフェンニ環化合物 |
DE60232170D1 (de) * | 2001-08-30 | 2009-06-10 | Alizyme Therapeutics Ltd | Thieno-(1,3)-oxazin-4-one mit lipase inhibierender wirkung |
CN1620439A (zh) | 2001-12-20 | 2005-05-25 | Osi药物公司 | 胰脂肪酶抑制剂化合物、其合成方法和应用 |
-
2002
- 2002-08-23 DE DE60232170T patent/DE60232170D1/de not_active Expired - Lifetime
- 2002-08-23 AT AT02755241T patent/ATE429918T1/de not_active IP Right Cessation
- 2002-08-23 NZ NZ531272A patent/NZ531272A/en not_active IP Right Cessation
- 2002-08-23 KR KR1020047002805A patent/KR100934256B1/ko not_active IP Right Cessation
- 2002-08-23 CN CN028185900A patent/CN1556706B/zh not_active Expired - Fee Related
- 2002-08-23 CA CA002458213A patent/CA2458213A1/en not_active Abandoned
- 2002-08-23 RU RU2004109588/04A patent/RU2324696C2/ru not_active IP Right Cessation
- 2002-08-23 US US10/488,045 patent/US7407954B2/en not_active Expired - Fee Related
- 2002-08-23 PL PL02368994A patent/PL368994A1/xx not_active Application Discontinuation
- 2002-08-23 EP EP02755241A patent/EP1446125B1/en not_active Expired - Lifetime
- 2002-08-23 HU HU0401298A patent/HUP0401298A3/hu unknown
- 2002-08-23 AU AU2002321536A patent/AU2002321536B2/en not_active Ceased
- 2002-08-23 WO PCT/GB2002/003903 patent/WO2003020282A1/en active IP Right Grant
- 2002-08-23 JP JP2003524589A patent/JP2005527469A/ja not_active Withdrawn
- 2002-08-23 MX MXPA04001922A patent/MXPA04001922A/es active IP Right Grant
- 2002-08-29 MY MYPI20023211A patent/MY139608A/en unknown
- 2002-08-30 AR ARP020103295A patent/AR036399A1/es unknown
-
2004
- 2004-02-25 ZA ZA2004/01595A patent/ZA200401595B/en unknown
- 2004-03-29 NO NO20041295A patent/NO20041295L/no not_active Application Discontinuation
- 2004-10-07 HK HK04107740.4A patent/HK1064940A1/xx not_active IP Right Cessation
-
2008
- 2008-07-24 US US12/178,920 patent/US20090029978A1/en not_active Abandoned
-
2010
- 2010-01-29 JP JP2010019160A patent/JP2010159260A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ZA200401595B (en) | 2005-05-25 |
NZ531272A (en) | 2006-01-27 |
CA2458213A1 (en) | 2003-03-13 |
EP1446125B1 (en) | 2009-04-29 |
MY139608A (en) | 2009-10-30 |
HUP0401298A2 (hu) | 2004-10-28 |
ATE429918T1 (de) | 2009-05-15 |
US20050075336A1 (en) | 2005-04-07 |
EP1446125A1 (en) | 2004-08-18 |
AR036399A1 (es) | 2004-09-08 |
JP2010159260A (ja) | 2010-07-22 |
AU2002321536B2 (en) | 2007-05-17 |
CN1556706A (zh) | 2004-12-22 |
RU2324696C2 (ru) | 2008-05-20 |
DE60232170D1 (de) | 2009-06-10 |
JP2005527469A (ja) | 2005-09-15 |
KR20040052216A (ko) | 2004-06-22 |
CN1556706B (zh) | 2011-04-27 |
RU2004109588A (ru) | 2005-05-10 |
WO2003020282A1 (en) | 2003-03-13 |
US7407954B2 (en) | 2008-08-05 |
PL368994A1 (en) | 2005-04-04 |
HK1064940A1 (en) | 2005-02-08 |
HUP0401298A3 (en) | 2008-03-28 |
US20090029978A1 (en) | 2009-01-29 |
KR100934256B1 (ko) | 2009-12-28 |
MXPA04001922A (es) | 2005-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7729A (is) | Bensónaþýridín með PDE 3/4 tálmunarvirkni | |
BR0000327B1 (pt) | cabeÇa de poÇo. | |
HK1061852A1 (en) | 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity | |
DK2308855T3 (da) | 2,4-Diaminopyrimidinderivater | |
MA25996A1 (fr) | Inhibiteurs de phosphodiesterase 4. | |
NL1014361A1 (nl) | Bevestigingsorgaan. | |
NO20040654L (no) | Gassmikrosfaere-liposomkompositter. | |
BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
ATE326467T1 (de) | Imidazo 1,2-aöpyridine | |
BR0201919B1 (pt) | colheitadeira. | |
NO20040387L (no) | Nedihullsfrigjoringskopling. | |
NO20041295L (no) | Tieno(1,3)oksazin-4-oner med lipaseinhiberende aktivitet | |
BR0103827B1 (pt) | cola - pds. | |
ES1050481Y (es) | Pieza de construccion. | |
ES1048400Y (es) | Bota-patin mejorada. | |
ES1050769Y (es) | Galleta perfeccionada. | |
ITMI20011465A0 (it) | Gene ad attivita' oncosoppressiva | |
ES1049872Y (es) | Azada perfeccionada. | |
ES1048873Y (es) | Descapsulador perfeccionado. | |
ES1050491Y (es) | Chupete infantil. | |
ES1044252Y (es) | Cabezal embuchador. | |
ES1048216Y (es) | Tapon-precinto perfeccionado. | |
ES1048659Y (es) | Canape perfeccionado. | |
ES1049008Y (es) | Picaporte perfeccionado. | |
ES1048870Y (es) | Capirote perfeccionado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |